Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on September 14, 2026

Sep. 14, 2026

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

Indeterminate GlobeNewswire

Sep. 14, 2026

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

Sep. 14, 2026

Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

Indeterminate GlobeNewswire

Sep. 14, 2026

Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors

Indeterminate GlobeNewswire

Sep. 14, 2026

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Indeterminate GlobeNewswire

Sep. 14, 2026

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Indeterminate GlobeNewswire

Sep. 14, 2026

Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)

Indeterminate GlobeNewswire

Sep. 14, 2026

GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

Indeterminate GlobeNewswire

Sep. 14, 2026

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

Indeterminate GlobeNewswire

Sep. 14, 2026

Sol y Vida Launches Nationwide Bilingual Telehealth Platform Built for Latino Communities

Indeterminate GlobeNewswire

Sep. 14, 2026

Etienna Bio Completes FDA INTERACT Meeting for ETB-001

Indeterminate GlobeNewswire

Sep. 14, 2026

WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC

Indeterminate GlobeNewswire

Sep. 14, 2026

BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients

Indeterminate GlobeNewswire

Sep. 14, 2026

Bio Usawa and Axmed Partner to Expand Access to Affordable Biologic Medicines Across Africa

Indeterminate GlobeNewswire

Sep. 14, 2026

Neue Daten zu Gotistobart zeigten annähernde Verdopplung des medianen Gesamtüberlebens im Vergleich zur Standardchemotherapie bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge

Indeterminate GlobeNewswire

Sep. 14, 2026

Humanity First unveils Masroor Centre for Healthcare, a new West Africa hub for critical care, cardiology and gastroenterology

Indeterminate GlobeNewswire

Sep. 14, 2026

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

Indeterminate GlobeNewswire

Sep. 14, 2026

Cellectis annonce sa transformation stratégique en société d'édition du génome in vivo

Indeterminate GlobeNewswire

Sep. 14, 2026

Avance Clinical 在台灣榮獲 ANZCham 澳洲台灣商業傑出貢獻獎

Indeterminate GlobeNewswire

Sep. 14, 2026

Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine

Indeterminate GlobeNewswire